Related Experiment Video
Updated: Jun 7, 2026
16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Dopamine boosts memory for angry faces in Parkinson's disease
Leena Subramanian1, John Vincent Hindle, Margaret Cecilia Jackson
1School of Psychology, Bangor University, Bangor, UK.
Summary
Dopamine medication impacts working memory in Parkinson's disease patients, improving recall for angry faces but hindering it for sad ones. This highlights dopamine's role in emotional-cognitive biases.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Psychiatry
Background:
- Emotion-cognition interactions are crucial for higher cognitive functions and are often disrupted in neuropsychiatric disorders.
- Dopamine pathways to the prefrontal cortex and basal ganglia are implicated in modulating these interactions.
Purpose of the Study:
- To investigate the role of dopamine in emotion-cognition interactions by examining working memory for emotional faces in Parkinson's disease patients.
- To assess the effects of dopaminergic medication on working memory performance for emotional stimuli.
Main Methods:
- Studied 25 patients with Parkinson's disease in both on and off medication states.
- Participants performed a working memory task involving emotional (happy, angry, sad, neutral, fearful) and neutral faces.
- Assessed recall of face identity while ignoring emotional expressions.
Main Results:
- Dopaminergic medication significantly enhanced working memory for angry faces.
- Dopaminergic medication significantly suppressed working memory for sad faces.
- Findings suggest dopamine modulates the saliency of threatening information.
Conclusions:
- Dopamine plays a role in altering emotional-cognitive biases rather than acting as a general cognitive enhancer.
- Results support cognitive mechanisms underlying the antidepressant effects of dopamine.
- Elucidates neurochemical underpinnings of emotion-cognition interplay in Parkinson's disease.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:23Role of Neurotransmitters in Memory
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...